Media Digest 11/30/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   UAE shares fell on Dubai debt problem news.

Reuters:   The Treasury will meet with mortgage companies to try to get them to accelerate loan modifications.

Reuters:   Holiday shoppers did not use credit cards as much as in the past.

Reuters:   Shoppers are increasing the use of e-commerce.

Reuters:   Shoppers spent less per person on Black Friday than a year ago.

Reuters:   Beijing Auto may have an interest in Saab.

Reuters:   Regulators have made a list of systematic risk firms.

WSJ:   A rift may be forming between Dubai and the UAE central bank.

WSJ:   Some failed banks cannot be sold at any price.

WSJ:   More shoppers went to stores over the Thanksgiving weekend, but they spent less.

WSJ:   Higher interest rates are threatening bank stocks.

WSJ:   More companies are becoming vertical through acquisitions.

WSJ:   Wall St. traders are beginning to spend large sums of money again.

WSJ:   The store debut of the Barnes & Noble (NYSE:BKS) Nook has been delayed.

WSJ:   US coal miners expect to cut output.

WSJ:   AOL plans to mass produce content using huge numbers of articles produced by outsiders.

WSJ:   Samsung handset sales are on track to exceed expectations.

WSJ:   Shopping via mobile phone is picking up.

WSJ:   The Apple (NASDAQ:AAPL) iPhone went on sales in South Korea.

WSJ:   R&D spending is staying strong.

WSJ:   Lenovo will by a mobile handset company.

WSJ:   More economists do not expect a strong recovery raising the question of how that will effect equity prices.

WSJ:   Credit ratings agencies are producing more independent reports.

WSJ:   Following Twitter is helping some companies predict near term sales.

WSJ:   More companies are outsourcing idea creation.

NYT:   Google (NASDAQ:GOOG) is working to gain ground on Yahoo! (NASDAQ:YHOO) in Japan.

FT:   India GDP growth was 7.9% in the third quarter.

FT:   There may be a bid for AIG’s (NYSE:AIG) aircraft leasing business.

FT:   GlaxoSmithKline (NYSE:GSK) will cut drug prices for developing countries.

Douglas A. McIntyre